<code id='6225828731'></code><style id='6225828731'></style>
    • <acronym id='6225828731'></acronym>
      <center id='6225828731'><center id='6225828731'><tfoot id='6225828731'></tfoot></center><abbr id='6225828731'><dir id='6225828731'><tfoot id='6225828731'></tfoot><noframes id='6225828731'>

    • <optgroup id='6225828731'><strike id='6225828731'><sup id='6225828731'></sup></strike><code id='6225828731'></code></optgroup>
        1. <b id='6225828731'><label id='6225828731'><select id='6225828731'><dt id='6225828731'><span id='6225828731'></span></dt></select></label></b><u id='6225828731'></u>
          <i id='6225828731'><strike id='6225828731'><tt id='6225828731'><pre id='6225828731'></pre></tt></strike></i>

          leisure time

          leisure time

          author:focus    Page View:19
          A device component from Paradromics Inc., one of the main brain-computer interface players racing to get to market. Courtesy Paradromics Inc.

          Rodney Gorham loves fast, flashy cars: His WhatsApp profile picture is a bright yellow Corvette Stingray. “I don’t get to drive it anymore,” Gorham told STAT in a text.

          Gorham, a 63-year-old living in Australia, has amyotrophic lateral sclerosis. He can’t speak, and can move his hands and legs only a little. But he is able to control his computer with his thoughts, aided by a brain-computer interface developed by the startup Synchron. 

          advertisement

          “It has been exciting to be involved,” Gorham wrote. 

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more
          ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?
          ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

          SusanGalbraith,AstraZeneca’sheadofcancerresearchanddevelopment,speaksataSTATeventin2023.MarieMillerf

          read more
          Tori Bowie and the unacceptable rates of Black maternal death
          Tori Bowie and the unacceptable rates of Black maternal death

          AlastairGrant/APThehorrorstoriesofBlackwomendyingorcomingclosetodeathinchildbirthneverseemtostopcomi

          read more

          Diversity in clinical trials starts with building trust, experts say

          SilasBuchanan,CEOofOurHealthyCommunity,speaksonapanelaboutdemocratizingclinicaltrialsattheMilkenInst